Specification,ATT,SE,t_stat,sig
"Main (CS, never-treated)",-0.187106905653304,0.14024795250052638,-1.3341150606287944,
Placebo: Male SE,-0.2762867787121572,0.20526455482700823,-1.3460033513579814,
Not-yet-treated control,-0.18481272189698444,0.14791277184560406,-1.2494710199190757,
Excluding California,-0.187106905653304,0.13378168144871638,-1.3985988487147938,
Incorporated SE only,-0.03933513414147862,0.07066146703313446,-0.5566702163575751,
Unincorporated SE only,-0.14777177151182522,0.10323563707594072,-1.4314027180664703,
Triple-diff (female-male gap),0.08917987305885317,0.14253489004848777,0.6256704798980502,
